Across
- 2. Study assessing Dapa in HFmrEF and HFpEF
- 4. Document with the aim of guiding medical decisions
- 7. The target organ of Dexiglofozin action
- 10. Deterioration of kidney function
- 11. Inhibited process by metformin
- 12. Release of metformin in Dexiglofozin Plus
- 14. Largest CVOT to assess hHF reduction of Dapa in 1ry and 2ry prevention patients
Down
- 1. Type-1 diabetes treatment
- 2. The active ingredient of Dexiglofozin
- 3. One pill of Dexiglofozin can provide many ....
- 5. Minimum eGFR to initiate Dexiglofozin
- 6. Degree of Dexiglofozin efficacy
- 8. Decreased pressure in the kidney as a benefit of Dexiglofozin
- 9. Excreted element in the urine with water and glucose by the effect of SGLT2i
- 13. Pressure under which the heart fills